arrow
C

Christopher Dunham

bc children’s hospital
H指数:32
被引数:4,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy

高风险髓母细胞瘤的定量表面组分析优先考虑癌胚抗原GPC2用于有效的CAR-T细胞疗法

2025-11-010
OAAI
High-resolution proteomic analysis of medulloblastoma clinical samples identifies MYC immunohistochemistry as a powerful outcome predictor outperforming genetic amplification detection

高分辨率蛋白质组学分析对髓母细胞瘤临床样本的研究确定了MYC免疫组化是一种强大的预后预测因子,其预测性能优于基因扩增检测。

2025-11-010
PRE
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma

整合的播散性儿童低级别胶质瘤临床与分子全景

2025-10-210
PRE
The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

编码4EBP1的EIF4EBP1基因被MYC转录上调,并与髓母细胞瘤的较短生存期相关。

2025-07-160
OAAI
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor

对髓母细胞瘤临床样本的高分辨率蛋白质组学分析鉴定出耐药亚组以及MYC免疫组化作为强有力的预后预测因子

2025-02-180
PRE
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

针对致死性儿童PFA室管瘤的整合表观遗传和代谢途径

2021-10-0630
OA
CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
2021-06-010
OAAI
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14

具有少突胶质细胞瘤样特征和核簇 (DGONC) 的弥漫性胶质神经元肿瘤-分子定义的胶质神经元CNS肿瘤类别,显示复发性单体性14

2020-02-0556
OAAI
Abnormal fatty acid metabolism is a core component of spinal muscular atrophy
2019-07-2690
OAAI
Heterogeneity within the PF-EPN-B ependymoma subgroup

Pf-epn-b室管膜瘤亚组内的异质性

2018-07-1790
OAAI
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
2017-07-21169
OAAI
Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis
2016-03-1732
OA
EZH2 Expression Is a Prognostic Factor in Childhood Intracranial Ependymoma: A Canadian Pediatric Brain Tumor Consortium Study
CANCER
IF5.1
2015-01-1330
OAAI